Fibrosis: Clinical Trials

33 trials for Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 terminated. 33 Phase 3, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 333Terminated 33
Phase 27Terminated 7

Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis

Trials (filtered) newest first · largest first

All 33 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate
FDC tablet (OCA 5 mg + BZF 400 mg SR) - Primary Biliary Cholangitis
Phase 3TerminatedIntercept Pharmaceuticals622024-07-012026-06-08
NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients
MAP-Target Algorithm - Acute Kidney Injury, Cirrhosis
Phase 2 / Phase 3TerminatedUniversity of California, San Francisco142024-02-012026-09-24
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension
INOpulse®, Placebo, Open Label Extension - Pulmonary Fibrosis, Pulmonary Hypertension
Phase 3TerminatedBellerophon Pulse Technologies1452020-12-142023-07-27
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Pamrevlumab, Placebo - Idiopathic Pulmonary Fibrosis
Phase 3TerminatedKyntra Bio3722020-09-302024-08-12
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
belapectin, Placebo - Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis
Phase 2 / Phase 3TerminatedGalectin Therapeutics Inc.3572020-06-252026-06-30
Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Pamrevlumab, Placebo - Idiopathic Pulmonary Fibrosis
Phase 3TerminatedKyntra Bio3932019-06-182024-09-19
CleanUP IPF for the Pulmonary Trials Cooperative
Antimicrobial therapy: Co-trimoxazole or Doxycycline, No Intervention: Standard of Care - Idiopathic Pulmonary Fibrosis
Phase 3TerminatedWeill Medical College of Cornell University5132017-03-222021-04-08
Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis
Proton-pump inhibitor, Propranolol+Proton-pump inhibitor - Liver Cirrhosis, Peptic Ulcer
Phase 2 / Phase 3TerminatedTaipei Veterans General Hospital, Taiwan102016-12-262020-06-23
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Elafibranor, Placebo - Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3TerminatedGenfit21572016-03-012022-03-23
Primary Prevention Hepatocellular Carcinoma by Metformin
Metformin, placebo tablet - Hepatocellular Carcinoma, Hepatitis C, Chronic
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris112015-06-012017-01-11
Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis
Hydrocortisone, NaCL 0.9% - Liver Cirrhosis
Phase 3TerminatedUniversitaire Ziekenhuizen KU Leuven1002015-01-012021-01-22
INR-Triggered Transfusion In GI Bleeders From ER
Transfuse plasma to High INR target, Transfuse plasma to Low INR target - Respiratory Distress Syndrome, Adult, Gastrointestinal Hemorrhage
Phase 3TerminatedUniversity of Colorado, Denver502011-07-012017-03-27
Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis
phlebotomy - Alcoholic Cirrhosis, Iron Overload
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris172011-05-012015-04-21
Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone
Dexamethasone, Placebo - Liver Cirrhosis
Phase 3TerminatedInsel Gruppe AG, University Hospital Bern22011-02-012013-04-18
Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis
Daptomycin + Meropenem, Ceftazidime - Cirrhosis, Ascites
Phase 2 / Phase 3TerminatedUniversity of Padova322010-10-012014-10-15
Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure
Norfloxacin, Placebo - Cirrhosis
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris2912010-04-012015-12-09
Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis
Sildenafil, Losartan, Sildenafil and Losartan - Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis
Phase 2 / Phase 3TerminatedAlicia Gerke122009-09-012018-11-13
Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
budesonide, budesonide placebo - Primary Biliary Cirrhosis
Phase 3TerminatedDr. Falk Pharma GmbH622009-02-012020-01-28
Albumin Administration in Cirrhotic Patients With Bacterial Infection and a Systemic Inflammatory Response Syndrome Unrelated to Spontaneous Bacterial Peritonitis
Human Albumin - Cirrhosis, Sepsis
Phase 3TerminatedCentre Hospitalier Universitaire de Besancon1932008-12-012014-05-13
Seprafilm® for Prevention of Adhesions at Repeat Cesarean
Seprafilm®, Control - Adhesion Formation After Primary Cesarean Delivery
Phase 3TerminatedAbington Memorial Hospital4502008-07-012015-12-30

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Liver Cirrhosis (11)  ·  Pulmonary Fibrosis (8)  ·  Idiopathic Pulmonary Fibrosis (7)  ·  Carcinoma, Hepatocellular (4)  ·  Hypertension, Portal (4)  ·  Ascites (3)  ·  Esophageal and Gastric Varices (3)  ·  Hepatitis C, Chronic (3)  ·  Lung Diseases (3)  ·  Sepsis (3)  ·  Hepatorenal Syndrome (2)  ·  Idiopathic Interstitial Pneumonias (2)  ·  Liver Cirrhosis, Biliary (2)  ·  Liver Neoplasms (2)

Broader conditions

Pathologic Processes (33)  ·  Pathological Conditions, Signs and Symptoms (33)  ·  Digestive System Diseases (21)  ·  Liver Diseases (20)  ·  Respiratory Tract Diseases (9)  ·  Infections (6)  ·  Lung Diseases (6)  ·  Lung Diseases, Interstitial (6)  ·  Disease Attributes (5)  ·  Gastrointestinal Diseases (5)  ·  Adenocarcinoma (4)  ·  Carcinoma (4)  ·  Digestive System Neoplasms (4)  ·  Neoplasms (4)

Interventions

Propranolol (2)  ·  Serum Albumin, Human (2)  ·  interferon gamma-1b (2)  ·  pamrevlumab (2)  ·  satavaptan (2)  ·  2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid (1)  ·  Albumins (1)  ·  Azathioprine (1)  ·  Bloodletting (1)  ·  Budesonide (1)  ·  Ceftazidime (1)  ·  Cisplatin (1)  ·  Daptomycin (1)  ·  Dexamethasone (1)  ·  Doxycycline (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (4)  ·  InterMune (3)  ·  University of Padova (3)  ·  Kyntra Bio (2)  ·  Sanofi (2)  ·  Abington Memorial Hospital (1)  ·  Alicia Gerke (1)  ·  Azienda Ospedaliera San Giovanni Battista (1)  ·  Bellerophon Pulse Technologies (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Dr. Falk Pharma GmbH (1)  ·  French National Agency for Research on AIDS and Viral Hepatitis (1)  ·  Galectin Therapeutics Inc. (1)  ·  Genfit (1)  ·  Insel Gruppe AG, University Hospital Bern (1)

Countries

United States (16)  ·  France (14)  ·  Italy (10)  ·  Germany (8)  ·  Argentina (7)  ·  Spain (7)  ·  Australia (6)  ·  Belgium (6)  ·  Canada (6)  ·  Czechia (6)  ·  United Kingdom (6)  ·  South Korea (5)  ·  Chile (4)  ·  Mexico (4)  ·  Denmark (3)

Top investigators

Alexander Wilmer, MD, PhD (1)  ·  Alicia K Gerke, MD (1)  ·  Amy Mackey, MD (1)  ·  Arun J Sanyal, M.D. (1)  ·  Ashika Ahmed (1)  ·  Carol Addy, MD MMSc (1)  ·  David Peleg, MD (1)  ·  Davide D'Amico, prof, MD (1)  ·  Dominique Roulot, MD (1)  ·  Eric Bellissant, MD, PhD (1)  ·  Eric Savier, MD (1)  ·  Fernando Martinez, MD, MS (1)  ·  Francesco Grigoletto, prof, M.D. (1)  ·  Franco Brunello, MD (1)

Results publications

PMID 21836029, PMID 19570573, PMID 24311766, PMID 25463545, PMID 25543678, PMID 28657784, PMID 30144431, PMID 31047956, PMID 32164673, PMID 32950590, PMID 33434107, PMID 33974018, PMID 35204752, PMID 35688625, PMID 38030064, PMID 38238788, PMID 38762797, PMID 39141673, PMID 40757786

NIH funding

2015 (1), U01HL128954 (1)